Growing Financials While currently a small company with revenue between 1M and 10M and funding of 6.3M, its progress toward clinical development signifies emerging market opportunities for biotech investors and service providers.

Niche Market Focus Targeting broad cancer indications with specialized small molecules positions Aminex as a promising partner for organizations providing research, diagnostics, or specialized oncology equipment.

Potential for Strategic Alliances As a clinical-stage biotech with innovative therapies, there is strong potential for forming strategic partnerships with larger pharmaceutical companies seeking early-stage oncology assets or research collaborations.